{"result": "(\"entity\"<|>DIABETES MELLITUS TYPE 2<|>EVENT<|>Diabetes mellitus type 2 is a chronic metabolic condition characterized by insulin resistance and high blood sugar levels, recognized as a significant health epidemic in the 21st century.)\n##\n(\"entity\"<|>DARIOS STUDY<|>EVENT<|>The DARIOS study is a population-based study conducted in Spain that assessed cardiovascular risk factors and reported a diabetes prevalence of 13% among the population.)\n##\n(\"entity\"<|>DI@BET STUDY<|>EVENT<|>The Di@bet study was conducted between 2008 and 2010 to evaluate the prevalence of diabetes in the Spanish adult population, finding a prevalence of 13.8%.)\n##\n(\"entity\"<|>OVIEDO<|>GEO<|>Oviedo is the capital city of the province of Asturias in northern Spain, where the Hospital Universitario Central de Asturias is located.)\n##\n(\"entity\"<|>SPAIN<|>GEO<|>Spain is a country in southwestern Europe, facing significant public health challenges related to diabetes mellitus.)\n##\n(\"relationship\"<|>DIABETES MELLITUS TYPE 2<|>DIABETES MELLITUS<|>Diabetes mellitus type 2 is a specific form of diabetes mellitus that is prevalent in the population<|>8)\n##\n(\"relationship\"<|>DARIOS STUDY<|>DIABETES MELLITUS<|>The DARIOS study provides data on the prevalence of diabetes mellitus in Spain<|>6)\n##\n(\"relationship\"<|>DI@BET STUDY<|>DIABETES MELLITUS<|>The Di@bet study highlights the prevalence of diabetes mellitus type 2 among the Spanish population<|>6)\n##\n(\"relationship\"<|>HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS<|>OVIEDO<|>The Hospital Universitario Central de Asturias is located in the city of Oviedo<|>9)\n##\n(\"relationship\"<|>SPAIN<|>DIABETES MELLITUS<|>Spain is experiencing a significant public health issue due to the rising prevalence of diabetes mellitus<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Pancorbo-Hidalgo PL, García-Fernandez FP, Ramírez-Pérez C. Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit. J Clin Nurs. 2001 Jul;10(4):482-90.\n\n32. Arizon Z, Shabat S, Shuval I Peisakh A, Berner Y Prevalence of diabetes mellitus in elderly patients received enteral nutrition long-term care service. Archives of Gerontology and Geriatrics. 2008; 47:383–393.\n\n33. González Infantino CA, González CD, Sánchez R, Presner N. Hyperglycemia and hypoalbuminemia as prognostic mortality factors in patients with enteral feeding. Nutrition 2013; 29: 497–501.\n\n34. Olveira G, García-Luna PP, Pereira JL, Rebollo I, García-Almeida JM, Serrano P, et al. GARIN Group Andalusian Group for Nutrition Reflection and Investigation. Recommendations of the GARIN group for managing non-critically ill patients with diabetes or stress hyperglycaemia and artificial nutrition. Nutr Hosp 2012;27:1837–49.\n\n35. Sanz París A, Álvarez Hernández J, Ballesteros-Pomar MD, Botella-Romero F, León-Sanz M, Martín-Palmero Á, Martínez Olmos MÁ, Olveira G. Evidence-based recommendations and expert consensus on enteral nutrition in the adult patient with diabetes mellitus or hyperglycemia. Nutrition. 2017;41:58-67.\n---\n# Artículos Especiales\n\n## La diabetes mellitus en España ¿es un problema?\n\nDr. Francisco Villazón González\n\nMédico Especialista en Endocrinología y Nutrición.\nHospital Universitario Central de Asturias. Oviedo.\n\n### Palabras clave\n\nDiabetes, Prevalencia, Coste, Tendencia mortalidad.\n\n### Resumen\n\nLa diabetes mellitus tipo 2 se ha catalogado como la epidemia del siglo XXI, tanto por el aumento de prevalencia experimentado en el siglo anterior como por la mayor frecuencia de problemas vasculares que presentan los pacientes con diabetes. Su impacto en el coste del sistema sanitario supone un problema para los gestores del sistema, tanto por coste directo como y especialmente por el indirecto. Sin embargo, la tasa de mortalidad por diabetes en España podría estar mejorando en las últimas décadas.\n\nLa diabetes mellitus tipo 2 es la enfermedad metabólica crónica más frecuente en nuestros días y se ha convertido en uno de los problemas de salud pública más graves de nuestro tiempo, tanto a nivel nacional como internacional. Su prevalencia está aumentando en todo el mundo y esta tendencia seguirá hasta el año 2045, pasando a nivel global de 425 millones en 2017 (8,8% de adultos de 20 a 79 años) a 629 millones (9,9%), de ellos el 50% sin diagnosticar¹.\n\nEn España se han realizado múltiples estudios con base poblacional sobre prevalencia de diabetes que la situaban entre el 4 y el 7% de la población², con un aumento en las dos últimas décadas del siglo pasado ligado probablemente al incremento en la prevalencia de obesidad³. En el estudio DARIOS⁴ se revisaron 11 estudios realizados en la primera década del siglo XXI con una metodología similar sobre factores de riesgo cardiovascular en España, mostrando de media una prevalencia de diabetes del 13% (16% en varones y 11% en mujeres), con un aumento respecto a estudios anteriores.\n\nEn el año 2012 se publicó el estudio Di@bet⁵ realizado entre los años 2008 y 2010 en una muestra de 5072 adultos de la población española, mayores de 18 años que detectó una prevalencia de diabetes del 13,8% con un 6% de diabetes desconocida lo que implicaba que cerca de 4 millones de españoles padecían diabetes tipo 2. Esta prevalencia es más alta en hombres que en mujeres y aumenta con la edad desde los\n\n32\n---\n18 años; en los hombres aumenta hasta los 75, mientras que en mujeres la incidencia crece de forma continua con la edad. Además el 3,9% mostraba glucemia basal alterada y un 9,2% intolerancia a la glucosa y un 2,2% ambas, de manera que solo un 71,4% de la población mostraba un normal metabolismo de los hidratos de carbono. Un factor clave para el incremento en la prevalencia de diabetes además del aumento en la prevalencia de obesidad ha sido la mejoría en la supervivencia de los diabéticos, gracias a las distintas terapias que permiten una mejora del control glucémico y sobre todo del control de las cifras del colesterol e hipertensión arterial.\n\nEl Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) ha reevaluado a lo largo de 2016-2017 la misma cohorte poblacional, habiéndose estudiado 2048 personas que no presentaban diabetes en el estudio inicial presentando en el marco del XXIX Congreso Nacional de la Sociedad Española\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>GARIN GROUP ANDALUSIAN GROUP FOR NUTRITION REFLECTION AND INVESTIGATION<|>ORGANIZATION<|>The GARIN Group is an organization focused on nutrition reflection and investigation, providing recommendations for managing patients with diabetes or stress hyperglycemia and artificial nutrition.)\n##\n(\"entity\"<|>HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS<|>ORGANIZATION<|>The Hospital Universitario Central de Asturias is a medical institution in Oviedo, Spain, specializing in endocrinology and nutrition.)\n##\n(\"entity\"<|>FRANCISCO VILLAZÓN GONZÁLEZ<|>PERSON<|>Dr. Francisco Villazón González is a specialist in endocrinology and nutrition at the Hospital Universitario Central de Asturias.)\n##\n(\"entity\"<|>DIABETES MELLITUS<|>EVENT<|>Diabetes mellitus type 2 is a chronic metabolic disease characterized by high blood sugar levels and is considered a significant public health issue.)\n##\n(\"entity\"<|>CIBERDEM<|>ORGANIZATION<|>The Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) is a biomedical research center focused on diabetes and associated metabolic diseases.)\n##\n(\"relationship\"<|>FRANCISCO VILLAZÓN GONZÁLEZ<|>HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS<|>Dr. Francisco Villazón González works as a specialist at the Hospital Universitario Central de Asturias<|>9)\n##\n(\"relationship\"<|>GARIN GROUP ANDALUSIAN GROUP FOR NUTRITION REFLECTION AND INVESTIGATION<|>CIBERDEM<|>The GARIN Group collaborates with CIBERDEM in research and recommendations related to diabetes and nutrition<|>5)\n##\n(\"relationship\"<|>DIABETES MELLITUS<|>GARIN GROUP ANDALUSIAN GROUP FOR NUTRITION REFLECTION AND INVESTIGATION<|>The GARIN Group provides recommendations for managing diabetes mellitus in patients<|>7)\n##\n(\"relationship\"<|>DIABETES MELLITUS<|>FRANCISCO VILLAZÓN GONZÁLEZ<|>Dr. Francisco Villazón González specializes in the treatment and management of diabetes mellitus<|>8)\n<|COMPLETE|>"}]}